Evidence map›Paper›PMID 27756234›Full record

ArticleBMC cancer2016

Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration.

Yue Yu, Ning Cui, Heng-Yu Li, Yan-Mei Wu, Lu Xu, Min Fang, Yuan Sheng

Open access · goldAbstract readComparative Study
In one paragraph

Article in BMC cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yue YuDepartment of Breast and Thyroid Surgery, Changhai Hospital, the Second Military Medical University, 168 Changhai Road, Yangpu District, Shanghai, 200433, China.
Ning CuiDepartment of Breast and Thyroid Surgery, Changhai Hospital, the Second Military Medical University, 168 Changhai Road, Yangpu District, Shanghai, 200433, China.
Heng-Yu LiDepartment of Breast and Thyroid Surgery, Changhai Hospital, the Second Military Medical University, 168 Changhai Road, Yangpu District, Shanghai, 200433, China.
Yan-Mei WuDepartment of Breast and Thyroid Surgery, Changhai Hospital, the Second Military Medical University, 168 Changhai Road, Yangpu District, Shanghai, 200433, China.
Lu XuDepartment of Breast and Thyroid Surgery, Changhai Hospital, the Second Military Medical University, 168 Changhai Road, Yangpu District, Shanghai, 200433, China.
Min FangDepartment of Breast and Thyroid Surgery, Changhai Hospital, the Second Military Medical University, 168 Changhai Road, Yangpu District, Shanghai, 200433, China.
Yuan ShengDepartment of Breast and Thyroid Surgery, Changhai Hospital, the Second Military Medical University, 168 Changhai Road, Yangpu District, Shanghai, 200433, China. sheng528yuan@smmu.edu.com.
Changhai Hospital · CNShangqiu First People's Hospital · CNSecond Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo evaluate the accuracy of sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy (NAC) in breast cancer patients with axillary lymph node (ALN) metastasis.

methodsA total of 122 patients with operable breast cancer were enrolled in this single-center retrospective study. Eighty patients were clinically diagnosed with a positive axillary lymph node (ALN) via imaging or physical examination (including 66 patients with biopsy-proven metastasis). The other 42 cases had a clinically negative ALN. After four sessions of neoadjuvant chemotherapy, patients were assigned to an ALN-positive or -negative group. The identification rate (IR) and false negative rate (FNR) were determined in the ALN-negative group.

resultsALN changed from positive to negative after NAC in 48 patients. Among them, 46 had at least one SLN resected (total IR = 95.8 %). Eight of the 46 SLN-negative patients had pathologically confirmed metastasis of at least one non-SLN (FNR = 36 %). Fifty-five of the 56 patients with a biopsy-proven negative ALN remained ALN negative. Furthermore, 54 of the 56 patients had at least one SLN resected (IR =98.2 %). Three SLN-negative patients of the 54 had at least one positive non-SLN (FNR = 10.7 %).

conclusionsDue to its high FNR, post-NAC SLNB is not recommended for breast cancer patients with ALN metastasis confirmed by biopsy, though their ALN may become negative after NAC. However, for operable breast cancer with negative ALN, post-NAC SLNB is feasible if the ALN remains clinically negative after NAC.

trial registrationRetrospective evaluation.

Indexed as

AdultAntineoplastic Combined Chemotherapy ProtocolsAxillaBreastBreast NeoplasmsFeasibility StudiesFemaleHumansLymphatic MetastasisMiddle AgedNeoadjuvant TherapyOutcome Assessment, Health CarePrognosisReproducibility of ResultsRetrospective StudiesSentinel Lymph Node

Identifiers

PMID27756234
PMCPMC5070128
OpenAlexW2534856330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.